Wall Street 24/7 has come up with an interesting list of world’s 15 top-selling pharmaceutical drugs, based on information obtained from IMS Health, a research firm. In reverse order, here are the 10 biggest blockbusters:
10. Avastin—a cancer treatment developed by Swiss pharmaceutical company the Roche Group. In 2014 global sales stood at $6.1 billion.
9. Rituxan/Mabthera—a treatment for non-Hodgkin lymphoma and chronic lymphoma leukemia. The drug is also manufactured by the Roche Group and sales stood at $6.6 billion in 2014.
8. Nexium—a treatment for symptoms of acid reflux disease. New research suggests a link between this drug and kidney disease, which may harm sales. Indeed this drug, manufactured by AstraZeneca, is the only one on this list which has seen sales decline: from $7.9 billion in 2013 to $7.7 billion in 2014.
7. Remicade—a treatment for arthritis, psoriasis and bowel diseases. Manufactured by Johnson & Johnson, the drug is used by over 2 million people worldwide and sales hit $8.1 billion in 2014.
6. Crestor—an anti-cholesterol drug manufactured by AstraZeneca which is the bestselling medicine of its kind. Sales in 2014 were at $8.5 billion.
5. Enbrel—a medicine intended to treat rheumatoid arthritis and psoriasis, which often happen jointly, Enbrel sales stood at $8.7 billion in 2014.
4. Abilify—this antipsychotic, developed by the Japanese Otsuka Group, treats schizophrenia and bipolar disorder. Sales were at a hefty $9.3 billion in 2014, but it’s set to face competition from generics when its patent expires in 2017.
3. Sovaldi—this hepatitis C drug, manufactured by Gilead Sciences, is notoriously expensive in the US, excluding many, at $81,000 for a 12-week treatment course. Total sales stood at a “healthy” $9.4 billion in 2014.
2. Lantus—this diabetes treatment is manufactured by the French company Sanofi and sold 10.3 billion in 2014.
1. Humira—this anti-arthritis drug is manufactured by AbbVie and can also treat psoriasis and bowel diseases. Sales hit a chart-topping $11.8 billion in 2014.